Best Growth Stocks To Consider - April 23rd

Key Points

• MarketBeat’s screener flags five Growth stocks to watch: Teledyne Technologies (TDY), Prologis (PLD), Ascendis Pharma (ASND), Canopy Growth (CGC), and Hamilton Lane (HLNE).
• These names were selected because they had the highest dollar trading volume among Growth stocks recently and fit the growth profile of faster revenue/earnings expansion, higher valuations, and greater price volatility.
• Notable examples: Teledyne supplies industrial digital imaging and semiconductor components, while Prologis is a global leader in logistics real estate; the list also includes a biotech (Ascendis), a cannabis producer (Canopy), and an alternative-asset manager (Hamilton Lane).

Teledyne Technologies, Prologis, Ascendis Pharma A/S, Canopy Growth, and Hamilton Lane are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow revenues and earnings faster than the overall market, usually because of innovative products, expanding markets, or scalable business models. They typically reinvest profits instead of paying dividends, carry higher valuations and greater price volatility, and attract investors seeking capital appreciation rather than income. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Teledyne Technologies (TDY)

Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.

Read Our Latest Research Report on TDY

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Read Our Latest Research Report on PLD

Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

Read Our Latest Research Report on ASND

Canopy Growth (CGC)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Read Our Latest Research Report on CGC

Hamilton Lane (HLNE)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Read Our Latest Research Report on HLNE

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.